Compliance Alert: Federal Scrutiny on Psychedelic Lobbying Practices

Federal complaints have been filed alleging improper lobbying and misuse of internal congressional data by two former members of Congress, Mimi Walters and Kyrsten Sinema, concerning psychedelic policy efforts. These allegations involve efforts to influence government officials and industry stakeholders.

One complaint, filed anonymously with the Office of Congressional Conduct (OCC), targets former Congresswoman Mimi Walters and the Association for Prescription Psychedelics (APP), alleging illegal dissemination of taxpayer-funded data. The other complaint concerns former Senator Kyrsten Sinema. These evolving controversies highlight a growing scrutiny on the lobbying practices surrounding psychedelic therapies, drawing attention from both the industry and Capitol Hill.